Clinical Study

Preserved Transcallosal Inhibition to Transcranial Magnetic Stimulation in Nondemented Elderly Patients with Leukoaraiosis

Table 2

Single-pulse TMS data from both hemispheres of patients and controls.

Left hemisphere Right hemisphere
PatientsControlsP valuePatientsControlsP value

rMT (%)44.60 ± 9.4146.87 ± 6.82NS42.47 ± 6.5447.13 ± 6.26NS
cSP (ms)81.07 ± 30.5570.93 ± 26.99NS90.53 ± 39.1773.93 ± 29.64NS
iSP latency (ms)44.26 ± 4.8145.26 ± 3.01NS46.00 ± 4.8544.13 ± 5.89NS
iSP duration (ms)11.07 ± 6.549.00 ± 5.17NS8.87 ± 7.386.33 ± 6.66NS
MEP latency (ms)21.15 ± 1.9420.66 ± 1.51NS20.84 ± 2.0220.00 ± 1.63NS
CMCT (ms)5.81 ± 1.076.29 ± 1.25NS5.71 ± 0.475.76 ± 1.20NS
CMCTF (ms)5.93 ± 1.176.02 ± 1.14NS5.64 ± 0.975.31 ± 1.15NS
MEP ratio0.39 ± 0.120.33 ± 0.09NS0.43 ± 0.130.46 ± 0.12NS
F-wave (mV)0.10 ± 0.040.11 ± 0.05NS0.13 ± 0.100.09 ± 0.04NS

All values are expressed as mean ± SD. rMT: resting motor threshold; cSP: controlateral silent period; iSP: ipsilateral silent period; MEP ratio: motor-evoked potential amplitude ratio; CMCT: central motor conduction time; CMCTF: central motor conduction time obtained with the F-wave; F-wave : F-wave amplitude; NS: not significant.